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The placenta plays a central role for the fetus
by providing nutrients and oxygen, but also
by acting as a barrier to prevent passage of
toxic substances, such as mercury. Both
organic forms of Hg, such as methylmer-
cury, and mercury vapor (Hg0) are well-
known neurotoxic agents, especially during
early development (1), which is the most
susceptible period.
Fish, mainly freshwater and large marine
predatory species, is the dominant source of
human exposure to MeHg (2,3). On the basis
of recent data showing developmental effects
of MeHg in children on the Faroe Islands (4),
the U.S. National Research Council found the
U.S. Environmental Protection Agency refer-
ence dose of 0.1 µg MeHg/kg body weight per
day scientiﬁcally justiﬁable (1). Thus, women
of childbearing age should avoid eating most
predatory ﬁsh, which often contain 0.3–1.0
mg MeHg/kg (5,6). The main source of expo-
sure to inorganic mercury (I-Hg) is dental
amalgam ﬁllings, which release Hg0 (7,8). The
intake and uptake of Hg2+ is negligible (9).
The concentration of I-Hg in the fetus has
been shown to be inﬂuenced by the number
of dental amalgam fillings in the mother
(10–12). An experimental study shows that
the fetal brain distribution and effects are simi-
lar after exposure to MeHg and Hg0 (13).
It is generally believed that MeHg and
Hg0 easily cross the placental barrier whereas
Hg2+ is trapped (1,3). Inhaled Hg0 is oxi-
dized to inorganic Hg2+ by catalase already
within the blood (3), but some Hg0 remains
in the circulation long enough to pass the
placental barrier (10,13,14). However, the
reported studies in which the different forms
of Hg in human placenta have been speci-
ated (15–20) do not show consistently that
I-Hg is the main Hg form in placenta.
To clarify this further, our aim was to
determine placental accumulation of the dif-
ferent forms of Hg. We also related the pla-
cental concentrations of different Hg species
to the maternal exposure, cord blood con-
centrations, and possible associations with
selenium, which has been shown to protect
against Hg toxicity both in human (in vitro)
and animal studies (2,21,22).
Subjects and Methods
The study group consisted of pregnant
women recruited from antenatal care units in
Stockholm, Sweden (12,23,24). We collected
blood samples at gestational week (GW) 36,
and umbilical cord blood and placentas at
delivery. We found that the women who
donated placentas (n = 119) were representa-
tive of those entering the study (n = 254) with
respect to age, parity, number of amalgam ﬁll-
ings, freshwater fish consumption, and Hg
and selenium concentrations in their blood at
GW 36. A self-administered questionnaire
asked questions regarding number of dental
amalgam ﬁllings (0, < 10, or > 10 ﬁllings) and
frequency of freshwater fish consumption
before pregnancy. In the analyses, we com-
pared MeHg levels in women eating freshwa-
ter ﬁsh once a month or more with levels in
those eating freshwater ﬁsh less often or never.
The study was carried out in accordance with
the Helsinki declaration and was approved by
the Ethics Committee at Karolinska Institutet.
We stored placentas frozen in acid-washed
containers until preparation and homogeniza-
tion, as described elsewhere (24,25). We
divided each placenta into six sections and
obtained three subsamples from each section.
Concentrations of elements varied substantially
among the subsamples. In order to obtain
homogeneous samples, we homogenized pla-
cental tissues in a metal-free food processor
(Hugin; Robot-Coupe, Le Perreaux, France).
Before homogenization, we sectioned placental
samples from the maternal surface through the
chorionic plate. We cut away the decidua
basalis and chorionic plate and sampled pri-
marily placental/throphoblastic tissues. We
cleaned the specimens of blood and blotted
them on ﬁlter paper. We determined the wet
weight concentrations of I-Hg and total mer-
cury (T-Hg) in whole placenta homogenate by
alkaline solubilization/reduction and cold-
vapor atomic ﬂuorescence spectrophotometry
(Merlin, PSA 10.023; P.S. Analytical Ltd.,
Orpington, Kent, UK) as previously described
for blood (12). We treated subsamples of 2.0
g with 5.0 mL L-cysteine (1%), 5.0 mL
NaOH (45%), and 6.0 mL NaCl (1%). To
complete the solubilization, we heated the
mixture at approximately 80–85°C for 30
min. We analyzed duplicate samples from all
solubilizates. By subtracting the concentration
of I-Hg from that of T-Hg, we achieved the
concentration of organic Hg. We anticipated
that the major part of the organic Hg fraction
would be in the form of MeHg.
The limit of detection (3 × SD of the
mean reagent blanks) for I-Hg in placenta was
0.10 µg/kg (range, 0.04–0.16 µg/kg) and for
T-Hg was 0.10 µg/kg (range, 0.06–0.13
µg/kg). None of the sample concentrations
was below the limit of detection. No reference
sample with certified Hg concentration is
available for placenta. To ensure the method’s
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Articles
We determined levels of inorganic mercury (I-Hg) and methylmercury in placentas from 119
Swedish women, not selected with respect to high exposure of mercury. Our objective was to
relate placental Hg species with maternal and fetal blood concentrations and to evaluate possible
associations with selenium. We performed the analyses using automated alkaline
solubilization/reduction and cold-vapor atomic fluorescence spectrophotometry. I-Hg levels in
placenta increased with an increasing number of maternal dental amalgam fillings (p < 0.001).
Despite placental accumulation (median, 1.3 µg/kg; range, 0.18–6.7 µg/kg wet weight), a sub-
stantial fraction of maternal blood I-Hg, probably as Hg0, reached the fetus. Although MeHg
transferred easily to the fetus, it also accumulated in the placenta. On average, 60% of placental
Hg was in the form of MeHg. The median concentration was 1.8 µg/kg (range, 0–6.2 µg/kg wet
weight), more than twice the maternal blood concentration. We found significant associations
between MeHg and selenium in both maternal and umbilical cord blood but not in the placenta.
The associations were particularly obvious in freshwater ﬁsh consumers, probably reﬂecting that
ﬁsh is a source of both MeHg and selenium. We found no correlations between I-Hg and sele-
nium. This study increases the understanding of Hg, in its different forms, in human placenta
and how they are related to maternal and fetal exposure. Key words: fetal exposure, human, inor-
ganic mercury, methylmercury, placenta, pregnancy, selenium. Environ Health Perspect
110:523–526 (2002). [Online 3 April 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p523-526ask/abstract.htmlaccuracy, we analyzed a reference blood sam-
ple (Seronorm 404108; Nycomed Co., Oslo,
Norway) in duplicate twice in each of the
seven analytical runs. No systematic change
over time could be detected. The obtained
mean value for T-Hg was 7.9 µg/L (range,
7.4–8.3 µg/L), well within the recommended
range of 6.7–8.4 µg/L. Recovery studies using
subsamples from one placenta homogenate
spiked with 0.1 ng I-Hg and 0.1 ng MeHg
gave average recoveries of 96% for both I-Hg
and T-Hg. The precision of the method,
expressed as coefficient of variation, was,
respectively, 3.4% and 3.8% for I-Hg and
T-Hg for the Seronorm sample and 9.4%
and 9.2% for the placenta homogenate.
Determination and analytical accuracy of Hg
in blood and selenium in serum and placen-
tas were satisfactory and have been previ-
ously described (12,24).
The data were not normally distributed.
We tested differences between groups for
significance using nonparametric tests
(Kruskal-Wallis and Mann-Whitney U).
However, when requirements of normally
distributed residuals were met, we used
Pearson’s correlation and multiple regression
analysis. We conducted all statistical analyses
with SPSS, version 9.0 for Windows (SPSS
Inc., Chicago, IL, USA).
Results
Table 1 shows the concentrations of I-Hg
and MeHg in the placentas, maternal blood,
and umbilical cord blood. I-Hg levels in pla-
centa were four times higher than those in
maternal and umbilical cord blood and were
highly associated with maternal blood concen-
trations (r2 = 0.66; p < 0.001; Figure 1) but
not inﬂuenced by maternal age or parity. We
also found an association between I-Hg levels
in placenta and in umbilical cord blood (r2 =
0.30; p < 0.001). As shown in Figure 2, pla-
cental I-Hg levels increased markedly with
increasing number of amalgam fillings (p <
0.001). We did not find any correlation
between MeHg and I-Hg levels in placenta,
before or after controlling for amalgam ﬁllings.
The MeHg level in placenta was more
than twice that in maternal blood but only
slightly higher than that in umbilical cord
blood. Figure 1 shows the correlation
between MeHg levels in placenta and mater-
nal blood (r2 = 0.72; p < 0.001). Also the
umbilical cord blood concentrations of
MeHg were correlated with placental con-
centrations (r2 = 0.74; p < 0.001). Placental
MeHg levels increased with maternal age
and with freshwater ﬁsh intake (multiple lin-
ear regression adjusted r2 = 0.14; p ≤ 0.003)
but was not inﬂuenced by parity.
We found significant positive correla-
tions between concentrations (mol/L) of
selenium and MeHg levels in maternal blood
or umbilical cord blood but not in placenta
(Table 2). Those correlations were more pro-
nounced in women reporting consumption
of freshwater ﬁsh. We found a tendency for
higher selenium concentrations in maternal
serum of women reporting eating freshwater
fish than in those who did not (mean, 81
µg/L, n = 8, and 72 µg/L, n = 84, respectively;
p = 0.06). The corresponding concentrations
were, respectively, in umbilical cord blood 56
µg/L and 51 µg/L (p = 0.28) and in placenta
201 µg/kg and 195 µg/kg (p = 0.31) (24). We
found no signiﬁcant correlations between I-
Hg and selenium levels in the different tissues.
Discussion
The present study of Swedish nonoccupa-
tionally exposed women with low intake of
freshwater ﬁsh shows large variations of I-Hg
and MeHg concentrations in placenta (range
up to 7 µg/kg). Both were highly associated
with the concentrations in maternal blood.
As previously shown in experimental
studies (14), I-Hg accumulated in the pla-
centa. The median placental concentration
was four times higher than that in maternal
blood and increased considerably with
increasing number of amalgam ﬁllings. Thus,
it seems likely that the I-Hg bound in pla-
centa originated from Hg0 released from
amalgam fillings and oxidized to Hg2+ by
catalase in the blood. MeHg is known to
slowly demethylate to inorganic Hg2+ in some
tissues (12,26); however, the low I-Hg levels
also in placentas with high MeHg concentra-
tions indicated negligible demethylation of
MeHg in the placenta in the present study.
Hg2+ may be bound to metallothionein,
which is rich in cysteine, in the placenta.
Placentas have high levels of metallothionein
(27) but relations to Hg levels have not been
studied. However, in utero exposure to Hg0
induced fetal brain metallothionein produc-
tion in rats (28). Although we know little
about the toxic effects of Hg on placental
functions, in vitro studies suggest that Hg2+
can affect the transfer of amino acids, placen-
tal oxygen consumption (29), enzyme activity
(30), and hormonal secretion (31).
Despite the marked placental accumula-
tion of I-Hg, the concentration of I-Hg in
umbilical cord blood was similar to that in
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Table 1. I-Hg and MeHg concentrations in placenta, maternal blood (GW 36), and umbilical cord blood. 
5th 95th
No. Median percentile percentile Maximum
I-Hg
Placenta (µg/kg) 119 1.3 0.40 4.7 6.7
Maternal blood (µg/L) 112 0.32 0.03 1.2 1.9
Cord blood (µg/L)  98 0.34 0.09 0.79 1.1
MeHg 
Placenta (µg/kg) 119 1.8 0.56 3.8 6.2
Maternal blood (µg/L) 112 0.73 0.19 2.1 2.8
Cord blood (µg/L)  98 1.4 0.26 3.8 4.8
Data on maternal and cord blood concentration have been published previously (12).
Figure 1. Regression between (A) placental and maternal I-Hg (y = 0.32 + 3.3x; p < 0.001) and (B) between
placental and maternal MeHg (y = 0.50 + 1.7x; p < 0.001) at GW 36.
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Figure 2. I-Hg in placenta in relation to maternal
dental amalgam ﬁllings: 0 ﬁllings (n = 8), < 10 ﬁll-
ings (n = 61), and > 10 fillings (n = 37). Boxes
depict 25th, 50th, and 75th percentiles, and
whiskers depict minimum and maximum values,
excluding outliers. 
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Outliersmaternal blood. We did not determine the
forms of I-Hg passing to the fetus because
the analytical method did not distinguish
between Hg0 and Hg2+. However, because
Hg2+ seems to cross the placental barrier only
at high concentrations (14,29), most I-Hg
likely passed to the fetus in the form of Hg0.
MeHg has been proposed to be readily
transported across the placenta bound to
thiol-groups in cysteine, thereby mimicking
methionine (32). Indeed, we found higher
MeHg concentrations in umbilical cord
blood than in maternal blood. However,
MeHg concentrations in placenta were
about twice those in maternal blood, show-
ing retention in placental tissue. In contrast
to the hypothesis that I-Hg is the primary
form of Hg that accumulates in placenta, an
average of 60% of the Hg in placenta was in
the form of MeHg. The formation of thiol-
MeHg bonds is likely responsible also for the
placental accumulation because MeHg, like
Hg2+, is known to bind to thiol-containing
molecules—for example, proteins, cysteine,
and glutathione (3). Whether this accumula-
tion of MeHg in placenta causes any adverse
effects in humans is not known. Studies on
mice have shown effects on the activity of
selenoenzymes, such as inhibition of glu-
tathione peroxidase, although the placental
concentration of selenium was not affected
(33). Glutathione peroxidase is an antioxida-
tive enzyme, and high levels are probably
needed in the placenta to protect the fetus
from the oxidative stress produced during
the metabolism of MeHg (34).
We found no correlation between sele-
nium and MeHg or I-Hg in placenta. The
selenium uptake in placenta seems to give
concentrations within a narrow range,
150–250 µg/kg (24). This range is far higher
than the concentrations of Hg (about 1.8
µg/kg as MeHg and 1.3 µg/kg as I-Hg).
Interestingly, we found a strong association,
on a molar basis, between serum selenium
and blood MeHg, but not I-Hg, only in the
few women who reported intake of freshwater
ﬁsh, and who probably consumed more ﬁsh
in general than the rest of the women. This
probably reﬂects the fact that ﬁsh is a major
source of both MeHg and selenium.
Previous studies also report associations
between total Hg and selenium in blood of
people eating marine ﬁsh (35,36). Although
a protective role of selenium against MeHg
toxicity have been shown in animal studies
and human in vitro studies (2,21), no epi-
demiologic studies have yet been able to
show such an effect in humans. Therefore,
the possible protective role of selenium
remains to be further investigated.
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Maternal Se Placenta Se  Cord Se
rp -Value No. rp -Value No. rp -Value No.
Maternal MeHg 
All 0.30* 0.008 78
Freshwater ﬁsh 0.79* 0.034 7
No freshwater ﬁsh 0.17 0.17 66
Placenta MeHg 
All 0.19 0.057 106
Freshwater ﬁsh –0.21 0.56 10
No freshwater ﬁsh 0.20 0.060 90
Cord MeHg
All 0.28* 0.014 77
Freshwater ﬁsh 0.43 0.39 6
No freshwater ﬁsh 0.20 0.10 66
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